Potential Usefulness of Streptococcus pneumoniae Extracellular Membrane Vesicles as Antibacterial Vaccines

Journal of Immunology Research

Volumn 2017, Issue , 2017, Pages

  Choi, Chi Won ^a,b   Park, Edmond Changkyun ^a,c,d   Yun, Sung Ho ^a   Lee, Sang Yeop ^a,d   Kim, Seung Il ^a,c,d   Kim, Gun Hwa ^a,b,c  

^a Korea Basic Science Institute (KBSI)   (South Korea)

^b Korea University   (South Korea)

^c University of Science and Technology (UST)   (South Korea)

^d Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL VACCINE; BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; PNEUMOCOCCUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CELL; BACTERIAL MEMBRANE; CELL CULTURE; CELL ISOLATION; CONTROLLED STUDY; DRUG ISOLATION; DRUG POTENCY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGENICITY; MEMBRANE VESICLE; MOUSE; NONHUMAN; PROTEIN ANALYSIS; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; A-549 CELL LINE; ANIMAL; BLOOD; CHEMISTRY; CYTOLOGY; DRUG DEVELOPMENT; EXOSOME; IMMUNOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; MICROBIOLOGY; PNEUMOCOCCAL INFECTIONS; ULTRASTRUCTURE; VACCINATION; VIRULENCE;

A549 CELLS; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; DRUG DISCOVERY; EXTRACELLULAR VESICLES; HUMANS; INJECTIONS, INTRAPERITONEAL; MICE; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; STREPTOCOCCUS PNEUMONIAE; VACCINATION; VIRULENCE;

EID: 85012110494     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2017/7931982     Document Type: Article

References (21)

1. R. A. Hirst, H. Yesilkaya, E. Clitheroe et al., "Sensitivities of human monocytes and epithelial cells to pneumolysin are different," Infection and Immunity, vol. 70, no. 2, pp. 1017-1022, 2002.
2. S. J. Kelly, K. B. Taylor, S. Li, and M. J. Jedrzejas, "Kinetic properties of Streptococcus pneumoniae hyaluronate lyase," Glycobiology, vol. 11, no. 4, pp. 297-304, 2001.
3. T. J.Mitchell, "Virulence factors and the pathogenesis of disease caused by Streptococcus pneumoniae," Research in Microbiology, vol. 151, no. 6, pp. 413-419, 2000.
4. M. van der Linden, A. Al-Lahham, W. Nicklas, and R. R. Reinert, "Molecular characterization of pneumococcal isolates from pets and laboratory animals," PLoS ONE, vol. 4, no. 12, Article ID e8286, 2009.
5. G. Oligbu,Y.Hsia, L. Folgori, S. Collins, and S. Ladhani, "Pneumococcal conjugate vaccine failure in children: a systematic review of the literature," Vaccine, vol. 34, no. 50, pp. 6126-6132, 2016.
6. A. Kulp and M. J. Kuehn, "Biological functions and biogenesis of secreted bacterial outer membrane vesicles," Annual Review of Microbiology, vol. 64, pp. 163-184, 2010.
7. C.-W. Choi, E. C. Park, S. H. Yun et al., "Proteomic characterization of the outer membrane vesicle of Pseudomonas putida KT2440," Journal of Proteome Research, vol. 13, no. 10, pp. 4298-4309, 2014.
8. E. N. T. Meeusen, J. Walker, A. Peters, P.-P. Pastoret, and G. Jungersen, "Current status of veterinary vaccines," Clinical Microbiology Reviews, vol. 20, no. 3, pp. 489-510, 2007.
9. G.-H. Kim, C. W. Choi, E. C. Park, S.-Y. Lee, and S. I. Kim, "Isolation and proteomic characterization of bacterial extracellular membrane vesicles," Current Protein and Peptide Science, vol. 15, no. 7, pp. 719-731, 2014.
10. G. Bjune, E. A. Hoiby, J. K. Gronnesby et al., "Effect of outer membrane vesicle vaccine against group B meningococcal disease inNorway,"TheLancet, vol. 338, no.8775, pp. 1093-1096, 1991.
11. D. R. Martin, S. J. Walker, M. G. Baker, and D. R. Lennon, "New Zealand epidemic of meningococcal disease identified by a strain with phenotype B:4:P1.4," Journal of Infectious Diseases, vol. 177, no. 2, pp. 497-500, 1998.
12. G. V. Sierra, H. C. Campa, N. M. Varcacel et al., "Vaccine against group B Neisseriameningitidis: protection trial andmass vaccination results in Cuba," NIPH Annals, vol. 14, no. 2, pp. 195-210, 1991.
13. J. Boslego, J. Garcia, C. Cruz et al., "Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile," Vaccine, vol. 13, no. 9, pp. 821-829, 1995.
14. C.-W. Choi, Y. G. Lee, S.-O. Kwon et al., "Analysis of Streptococcus pneumoniae secreted antigens by immuno-proteomic approach," Diagnostic Microbiology and Infectious Disease, vol. 72, no. 4, pp. 318-327, 2012.
15. A. Olaya-Abril, R. Prados-Rosales, M. J. McConnell et al., "Characterization of protective extracellular membranederived vesicles produced by Streptococcus pneumoniae," Journal of Proteomics, vol. 106, pp. 46-60, 2014.
16. E.-Y. Lee, D.-Y. Choi, D.-K. Kim et al., "Gram-positive bacteria producemembrane vesicles: proteomics-based characterization of Staphylococcus aureus-derived membrane vesicles," Proteomics, vol. 9, no. 24, pp. 5425-5436, 2009.
17. J.Rivera, R. J. B. Cordero, A. S.Nakouzi, S. Frases,A.Nicola, and A. Casadevall, "Bacillus anthracis produces membrane-derived vesicles containing biologically active toxins," Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 44, pp. 19002-19007, 2010.
18. Y. Jiang, Q. Kong, K. L. Roland, and R. Curtiss, "Membrane vesicles of Clostridium perfringens type A strains induce innate and adaptive immunity," International Journal ofMedical Microbiology, vol. 304, no. 3-4, pp. 431-443, 2014.
19. A. M. Mitchell and T. J. Mitchell, "Streptococcus pneumoniae: virulence factors and variation," Clinical Microbiology and Infection, vol. 16, no. 5, pp. 411-418, 2010.
20. B. van de Waterbeemd, M. Streefland, P. van der Ley et al., "Improved OMV vaccine against Neisseria meningitidis using genetically engineered strains and a detergent-free purification process," Vaccine, vol. 28, no. 30, pp. 4810-4816, 2010.
21. T.N. Ellis and M. J. Kuehn, "Virulence and immunomodulatory roles of bacterial outer membrane vesicles," Microbiology and Molecular Biology Reviews, vol. 74, no. 1, pp. 81-94, 2010.